Ads
related to: biotechnology
Search results
Airbnb upgraded, Southwest downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 3 hours agoThe firm believes Medpace is an attractive investment opportunity given its industry-leading organic...
Smart Money Is Betting Big In NVAX Options - Novavax (NASDAQ:NVAX)
Benzinga· 1 hour agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish ...
Earnings call: Nanobiotix reports Q1 2024 results, advances with NBTXR3 By Investing.com
Investing.com· 5 days agoNanobiotix (Euronext: NANO), a leading biotechnology company, shared updates on their corporate...
Traders Buy Large Volume of Put Options on iShares Biotechnology ETF (NASDAQ:IBB)
ETF DAILY NEWS· 5 days agoiShares Biotechnology ETF (NASDAQ:IBB – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors purchased 70,278 put options on ...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks· 4 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent quarters. Stiff competition in the target market is also a woe.
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Lowered by Swiss National Bank
ETF DAILY NEWS· 13 hours agoSwiss National Bank reduced its position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 9.1% during the 4th quarter, according to the company in its most recent disclosure with ...
Swiss National Bank Reduces Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
ETF DAILY NEWS· 13 hours agoSwiss National Bank decreased its holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 10.3% during the fourth quarter, according to the company in its most recent ...
Adaptive Biotechnologies Corp (ADPT) Shares Down Despite Recent Market Volatility – News Heater
NewsHeater· 5 days agoAdaptive Biotechnologies Corp (NASDAQ: ADPT)’s stock price has decreased by -3.16 compared to its previous closing price of 3.46. Is It Worth Investing in Adaptive Biotechnologies Corp (NASDAQ ...
Lineage Cell Therapeutics CEO buys $10,500 in company shares By Investing.com
Investing.com· 4 hours ago(NYSEAMERICAN:LCTX), acquired additional shares of the company's stock. On May 24, 2024, Culley...
St. Louis firm, backed by $200M in funding, gets regulatory nods to ‘expedite’ review of cancer drug...
The Business Journals· 21 hours agoSt. Louis biotechnology startup Wugen, which has raised more than $200 million in venture funding as...